Background: Gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (T2DM) represent two different components of the spectrum of diabetes mellitus (DM). Women with GDM have a high chance of developing T2DM in later life and this relative risk depends on a number of factors including ethnicity. Aim: To compare and estimate the risk of developing T2DM in South Asian women with a history of GDM compared to those without a history of GDM. Methods: This is a systematic review of PubMed and MEDLINE articles reporting the progression of GDM to T2DM that were published in English from 2000 to 2020. We performed meta-analysis to calculate risk ratios (RR). Results: We selected 6 studies considering the inclusion and exclusion criteria after sorting 25 full-text articles. Of the 44165 South Asian women assessed, 3095 had GDM and 41070 were without GDM. 995 women in GDM group and 1525 women in non-GDM group had developed T2DM. The RR of women with GDM over non-GDM in developing T2DM was 10.81 (95% confidence interval (CI): 7.61–15.35) suggesting that women with GDM are at 10.81 times more risk of developing T2DM than non-GDM. The cumulative incidence of T2DM in GDM group was 17.34% at 5 years of follow-up and 33% at more than 10 years of follow-up. Conclusion: The risk of developing T2DM in later life is higher in South Asian women with GDM than without GDM. Therefore, lifestyle and pharmacological interventions, patient communication, timely screening, and long-term follow-up of GDM patients are important to reduce the risk.

Objective: The aim of the study has been to investigate the possible hypolipidemic and antioxidant properties of the whole plant extract of Ipomoea aquatica in experimentally induced hyperlipidemia in rabbits.Methods: Ethanolic extract of I. aquatica whole plant (EEIAWP) was prepared by percolation method. The extract was evaluated for hypolipidemic and antioxidant activities using 400 mg/kg body weight per day in a high fat diet induced hyperlipidemia in rabbits. The results were analyzed using one-way analysis of variance (ANOVA) followed by Bonferroni's multiple comparison tests and compared to the normal control, experimental control and the standard drug (atorvastatin 2.1 mg/kg body weight per day) groups. The results were expressed as mean±standard error of mean (SEM). Values with p<0.05 were considered significant. Results:Oral administration of EEIAWP in the test group showed a significant reduction in the serum levels of total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and a significant increase in the high-density lipoprotein cholesterol (HDL-C) when compared to the experimental control group. There were also significantly elevated catalase and superoxide dismutase (SOD) activities and significantly lower malondialdehyde (MDA) levels in the test group compared to the experimental group. Similar results were also found in the standard drug group. Conclusion:The results of our experiment demonstrated that EEIAWP possesses significant antihyperlipidemic and antioxidant activities and hence could be a potential source of medication as an adjuvant to the existing therapy for treatment of dyslipidemia.

Background: Adverse drug reactions (ADR) are one of the major reason of morbidity, mortality and increase in health-care costs. The pharmacovigilance programme of India (PvPI) encourages the active participation of all health care professionals (HCP) in reporting suspected ADR to ensure enhanced patient safety. But present statistics shows under reporting of suspected ADR. So, this study was undertaken with the objectives of assessing knowledge, attitude and practice (KAP) of pharmacovigilance among the HCP and to evaluate various reasons of under reporting of suspected ADR.Methods: This is a cross-sectional observational study of knowledge, attitude and practice (KAP) of HCP including faculties, resident doctors and postgraduate trainee (PGT), internship doctors and nurses on pharmacovigilance; conducted at department of Pharmacology, Jorhat Medical College and Hospital(JMCH). The pretested and peer reviewed questionnaire was distributed among 150 HCP and the responses were collected after one day. Data were analyzed using MS-excel software and was expressed in percentage.Results: Out of 150 questionnaires, 118 responses were received (32 faculties, 27 PGT, 38 internship doctors and 21 nurses). Good knowledge (78.4%) and fair attitude was found among the HCP but there was lack of practice of pharmacovigilance due to reasons mainly non availability of suspected ADR reporting form (27.1%), didn’t think reporting was necessary (34%), fear of consequences (16.1%) and lack of awareness (16.1%) among others.Conclusions: Good attitude was observed among HCP. With proper measures like sensitization and educational intervention ADR, reporting may be improved in the future.